NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate
Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate

NCT07664527

Not Yet RecruitingPhase 4

Sponsor: University of Wisconsin, Madison

Conditions: Asthma

Interventions: Fluticasone Propionate, Water Mouthwash, EVOOW Mouthwash

Countries: United States

This study is to find out if an Extra Virgin Olive-Oil-based Water (EVOOW) mix, removes more Fluticasone Propionate (FP) from the mouth than Water alone. 2 strengths of the EVOOW mix will be tested, one with equal parts EVOO and Water (50/50) and one with 3 parts EVOO and 1 part Water (75/25). Removing more FP deposits may help decrease the risk for obstructive sleep apnea (OSA), candidiasis (thrush), and speech and swallow dysfunction. Participants will be on study for up to 3 weeks.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Healthy adults and adults with asthma, age 18 years and older
* Willing to hold orally and nasally inhaled corticosteroids (ICS) for 24h and 12h, respectively, before study visits with mouthwash sample collections (Visit 2 and Visit 3)
* No systemic or topical ocular corticosteroid use for the prior 4 weeks.

Exclusion Criteria:

* Known hypersensitivity to fluticasone propionate
* Allergy to olives or olive oil
* Known allergy to oxymetazoline
* Current smoking or vaping
* Currently pregnant or trying to become pregnant.
Locations (1)
  • Madison, Wisconsin, United States